|
Título:
|
Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries
|
|
Autores:
|
Alonso, J. ;
Liu, Z. ;
Evans-Lacko, S. ;
Sadikova, E. ;
Sampson, N. ;
Chatterji, S. ;
Abdulmalik, J. ;
Aguilar-Gaxiola, S. ;
Al-Hamzawi, A. ;
Andrade, L.H. ;
Bruffaerts, R. ;
Cardoso, G. ;
Cia, A. ;
Florescu, S. ;
de Girolamo, G. ;
Gureje, O. ;
Haro, J.M. ;
He, Y. ;
de Jonge, P. ;
Karam, E.G. ;
Kawakami, N. ;
Kovess-Masfety, V. ;
Lee, S. ;
Levinson, D. ;
Medina-Mora, M.E. ;
Navarro-Mateu, F. ;
Pennell, B.E. ;
Piazza, M. ;
Posada-Villa, J. ;
ten Have, M. ;
Zarkov, Z. ;
Kessler, R.C. ;
Thornicroft, G. ;
WHO World Mental Health Survey
|
|
Tipo de documento:
|
texto impreso
|
|
Editorial:
|
Wiley, 2019-04-24T18:23:52Z
|
|
Nota general:
|
info:eu-repo/semantics/restrictedAccess
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
|
|
Idiomas:
|
Inglés
|
|
Palabras clave:
|
Editados por otras instituciones
,
Artículos
,
Artículos en revistas indizadas
|
|
Resumen:
|
Background: Anxiety disorders are a major cause of burden of disease. Treatment gaps have been described, but a worldwide evaluation is lacking. We estimated, among individuals with a 12-month DSM-IV (where DSM is Diagnostic Statistical Manual) anxiety disorder in 21 countries, the proportion who (i) perceived a need for treatment; (ii) received any treatment; and (iii) received possibly adequate treatment. Methods: Data from 23 community surveys in 21 countries of the World Mental Health (WMH) surveys. DSM-IV mental disorders were assessed (WHO Composite International Diagnostic Interview, CIDI 3.0). DSM-IV included posttraumatic stress disorder among anxiety disorders, while it is not considered so in the DSM-5. We asked if, in the previous 12 months, respondents felt they needed professional treatment and if they obtained professional treatment (specialized/general medical, complementary alternative medical, or nonmedical professional) for “problems with emotions, nerves, mental health, or use of alcohol or drugs.” Possibly adequate treatment was defined as receiving pharmacotherapy (1+ months of medication and 4+ visits to a medical doctor) or psychotherapy, complementary alternative medicine or nonmedical care (8+ visits). Results: Of 51,547 respondents (response = 71.3%), 9.8% had a 12-month DSM-IV anxiety disorder, 27.6% of whom received any treatment, and only 9.8% received possibly adequate treatment. Of those with 12-month anxiety only 41.3% perceived a need for care. Lower treatment levels were found for lower income countries. Conclusions: Low levels of service use and a high proportion of those receiving services not meeting adequacy standards for anxiety disorders exist worldwide. Results suggest the need for improving recognition of anxiety disorders and the quality of treatment.
|
|
En línea:
|
http://doi.org/10.1002/da.22711
|
